ReutersAstraZenecas Covid vaccine was 79% efficient in preventing symptomatic health problem, according to information published Monday from a 32,000-plus individual stage 3 trial in the U.S. and in Latin America. The two-shot vaccine likewise revealed 100% effectiveness in avoiding extreme disease and hospitalization. AstraZeneca plans to file with the FDA for emergency usage permission in April. The most recent trial data comes as a number of European countries momentarily suspended the usage of AstraZenecas vaccine following reports of embolism. AstraZeneca stated Monday that an independent board identified no security issues associated with the firms shot.3. Covid cases increasing in 21 states as guvs unwind restrictionsWalgreens staff prepare vaccines for Educational Staff at Kettering City Schools to receive the Covid-19 vaccine as a part of Ohios Phase 1B vaccine distribution in Dayton, Ohio on February 10, 2021. Megan Jelinger

AstraZeneca vaccine found to be 79% efficient in U.S. trialA vial labelled with the AstraZeneca coronavirus illness (COVID-19) vaccine is seen in this illustration image taken March 19, 2021. ReutersAstraZenecas Covid vaccine was 79% efficient in avoiding symptomatic illness, according to data released Monday from a 32,000-plus person stage 3 trial in the U.S. and in Latin America. The two-shot vaccine likewise showed 100% effectiveness in avoiding severe disease and hospitalization. Covid cases increasing in 21 states as governors unwind restrictionsWalgreens staff prepare vaccines for Educational Staff at Kettering City Schools to get the Covid-19 vaccine as a part of Ohios Phase 1B vaccine distribution in Dayton, Ohio on February 10, 2021. Following Sundays statement, shares of Kansas City Southern rose about 17% in the premarket, while shares of Canadian Pacific Railway dropped about 2.5%.

By